MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Penumbra Company Profile (NYSE:PEN)

Consensus Ratings for Penumbra (NYSE:PEN) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.33 (11.99% downside)

Analysts' Ratings History for Penumbra (NYSE:PEN)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016Canaccord GenuityReiterated RatingBuy$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Wells FargoReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015Bank of AmericaInitiated CoverageBuy -> Buy$46.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015JPMorgan Chase & Co.Initiated CoverageOverweight$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Penumbra (NYSE:PEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/9/2016        
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Penumbra (NYSE:PEN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Penumbra (NYSE:PEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Penumbra (NYSE:PEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Penumbra (NYSE:PEN)
DateHeadline
06/28/16 10:37 AMPenumbra, Inc. (NYSE:PEN) Broker Price Targets For The Coming Week - Fiscal Standard
06/28/16 10:37 AMTop Stock Pick for Quarter: Penumbra, Inc. (NYSE:PEN) - Engelwood Daily
06/26/16 10:15 AMStock Tracing Lower on the Week Penumbra, Inc. (NYSE:PEN) - Engelwood Daily
06/26/16 10:15 AMNoticeable Analyst's ideas: MediciNova, Inc. (NASDAQ:MNOV) , Penumbra, Inc. (NYSE:PEN) - Street Updates
06/23/16 08:28 AMPenumbra, Inc. (NYSE:PEN) take heat post earnings - iStreetWire
06/20/16 07:22 AMPenumbra, Inc. (NYSE:PEN) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 06:01 PMNeurointerventional Devices Market Opportunity Assessment by 2025
06/16/16 09:57 AMIntracranial Stents Market : Size, Share, Development, Growth and Demand Forecast to 2015 – 2021
06/13/16 07:34 AMWhy Penumbra (PEN) Could Be Positioned for a Surge? -
06/09/16 08:45 AMHealthcare Highs: Medtronic plc (NYSE:MDT), Nevro Corp. (NYSE:NVRO), Penumbra, Inc. (NYSE:PEN), DENTSPLY ... - KC Register
06/09/16 05:09 AMPENUMBRA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/07/16 07:05 AMPenumbra (PEN) in Focus: Stock Adds 5.5% in Session -
06/03/16 08:30 AMRedmile Group Sticking With Healthcare Picks After Rough Q1 -
06/02/16 06:10 PMStock Review and Earnings Check on Penumbra Inc (NYSE:PEN) - HNN - Stock Review and Earnings Check on Penumbra Inc (NYSE:PEN)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Penumbra Inc (NYSE:PEN) to ...
06/02/16 06:10 PMAnalysts Set $54.33 Price Target for Penumbra Inc (NYSE:PEN) - Let Me Know About This - Analysts Set $54.33 Price Target for Penumbra Inc (NYSE:PEN)Let Me Know About ThisPenumbra logo Penumbra Inc (NYSE:PEN) has earned a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that cover the company, Zacks Investment Research reports. Four equities research analysts have rated the stock with a strong ...
06/02/16 08:47 AMBuy, Sell Or Hold Rating For Penumbra, Inc. (NYSE:PEN)? - Share Trading News - Buy, Sell Or Hold Rating For Penumbra, Inc. (NYSE:PEN)?Share Trading News12/16/2015 – Penumbra, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 60 price target on the stock. 10/13/2015 – Bank of America Merrill Lynch began new coverage on Penumbra, Inc. giving the company a “buy” ...
05/31/16 09:35 AMStock Paining Investors: Penumbra, Inc. (NYSE:PEN) - HNN - Stock Paining Investors: Penumbra, Inc. (NYSE:PEN)HNNPenumbra, Inc. (NYSE:PEN)'s P/E is 1301.71. P/E ratio indicates that a stock's price might be too high or too low when compared to its earnings. There are some investors who might think that a company with a high P/E is overpriced, though sometimes ...and more »
05/26/16 07:06 PMETF’s with exposure to Penumbra, Inc. : May 27, 2016 -
05/26/16 05:10 AMStock Rating Review for Penumbra Inc (NYSE:PEN) - Wall Street Hints and News - Stock Rating Review for Penumbra Inc (NYSE:PEN)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1 on shares of Penumbra Inc (NYSE:PEN). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is compiled by ...
05/23/16 07:34 AMPenumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : May 23, 2016 -
05/20/16 11:31 AMNoteworthy Stocks: GLOBAL BLOOD THERAPEUTICS, INC. (NASDAQ:GBT) , Penumbra, Inc. (NYSE:PEN) - Street Updates - Noteworthy Stocks: GLOBAL BLOOD THERAPEUTICS, INC. (NASDAQ:GBT) , Penumbra, Inc. (NYSE:PEN)Street UpdatesGLOBAL BLOOD THERAPEUTICS, INC. (NASDAQ:GBT) accumulated +7.63%, closing at $20.73 after floating between $19.03 and $20.78. The company has market capitalization of $632.91M. It has twelve month low of $12.24 and twelve month high of ...and more »
05/19/16 11:52 AMAnalyst Rating Check on Penumbra Inc (NYSE:PEN) - Wall Street Hints and News - Analyst Rating Check on Penumbra Inc (NYSE:PEN)Wall Street Hints and NewsCurrently, sell-side analysts have provided a consensus stock rating of 1 on shares of Penumbra Inc (NYSE:PEN). Analysts that cover the company will usually offer Buy, Sell, or Hold recommendations based on in-depth research. This consensus number is ...and more »
05/18/16 12:04 PMPENUMBRA INC Financials -
05/18/16 11:16 AMRevenue Update on Penumbra Inc(NYSE:PEN) - Trade Calls - Revenue Update on Penumbra Inc(NYSE:PEN)Trade CallsPenumbra Inc(NYSE:PEN) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 9, 2016. Company reported revenue of $57.92M. Analysts estimated a revenue of $53.10M. Earnings per share were ...Penumbra, Inc. Common Stock (NYSE:PEN) Trading Down - Insiders Selling, Short Interest GrowingFinance DailyPenumbra Incorporated (NYSE:PEN) Sellers Covered 5.56% of Their ShortsThe Postall 3 news articles »
05/17/16 02:42 PMPenumbra, Inc. :PEN-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 03:18 PMETF’s with exposure to Penumbra, Inc. : May 16, 2016 -
05/13/16 07:08 AMPenumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : May 13, 2016 -
05/11/16 10:49 AMConsensus Rating Review for Penumbra Inc (NYSE:PEN) - B.O.D.Y Confidential - Consensus Rating Review for Penumbra Inc (NYSE:PEN)B.O.D.Y ConfidentialOne of these bases is following what opinions professional research analysts have on a particular stock. Equity research analysts currently have a consensus rating of 1 on shares of Penumbra Inc (NYSE:PEN). Sell-side analysts will typically rate a ...and more »
05/10/16 10:58 AMPenumbra, Inc. Reports First Quarter 2016 Financial Results - PR Newswire (press release) - NewsWay 21Penumbra, Inc. Reports First Quarter 2016 Financial ResultsPR Newswire (press release)Penumbra, Inc. will host a conference call to discuss the first quarter 2016 financial results after market close on Monday, May 9, 2016 at 4:30 PM Eastern Time. The conference call can be accessed live over the phone by dialing (877) 201-0168 for ...Penumbra, Inc. (NYSE:PEN) Latest Broker CoverageRisers & FallersPenumbra Inc (PEN) Posts Earnings Results, Beats Estimates By $0.09 EPSNewsWay 21Penumbra Inc (PEN) Announces Earnings Results, Beats Expectations By $0.09 EPSWeb Breaking NewsMarket Digest -Nasdaqall 7 news articles »
05/10/16 08:19 AMPenumbra (PEN) Q1 Earnings & Revenues Beat Expectations -
05/09/16 09:04 PMEdited Transcript of PEN earnings conference call or presentation 9-May-16 8:30pm GMT -
05/09/16 04:22 PMPenumbra posts 1Q profit -
05/09/16 04:14 PMPENUMBRA INC Files SEC form 8-K, Results of Operations and Financial Condition -
05/09/16 03:18 PMPenumbra, Inc. Reports First Quarter 2016 Financial Results - [at noodls] - ALAMEDA, Calif., May 9, 2016 /PRNewswire/ -- Penumbra, Inc.(NYSE: PEN), a global interventional therapies company, today reported financial results for the first quarter ended March 31, 2016. Revenue of ...
05/09/16 03:07 PM4:07 pm Penumbra beats by $0.09, beats on revs -
05/09/16 10:54 AMAfter Last Week What Do Analysts Think Of Penumbra, Inc. (NYSE:PEN) - Share Trading News - After Last Week What Do Analysts Think Of Penumbra, Inc. (NYSE:PEN)Share Trading News10/13/2015 – Wells Fargo began new coverage on Penumbra, Inc. giving the company a “outperform” rating. The share price of Penumbra, Inc. (NYSE:PEN) was up +0.39% during the last trading session, with a day high of 56.24. 287555 shares were traded ...Regis Management Co adds Penumbra Inc (PEN) to its portfolioMarket Digestall 2 news articles »
05/09/16 06:07 AMQ1 2016 Penumbra Inc Earnings Release - After Market Close -
05/07/16 10:28 AMEarnings Outlook on Penumbra Inc (NYSE:PEN) - B.O.D.Y Confidential - Earnings Outlook on Penumbra Inc (NYSE:PEN)B.O.D.Y ConfidentialAnalysts and investors will be anticipating Penumbra Inc (NYSE:PEN)'s next earnings release which is expected to be posted on or around 2016-05-09. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.06 for the ...and more »
05/06/16 08:33 AMMed Instruments Stocks' Q1 Earnings: PEN, INGN, OPKO, NVRO -
05/05/16 08:53 AMPenumbra (PEN): What Will Q1 Earnings Release Unveil? -
05/04/16 10:28 AMAverage Analyst Rating for Penumbra Inc (NYSE:PEN) - B.O.D.Y Confidential - Average Analyst Rating for Penumbra Inc (NYSE:PEN)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on Penumbra Inc (NYSE:PEN) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
04/30/16 10:43 AMShare Performance and Target Price Review Penumbra Inc (NYSE:PEN) - B.O.D.Y Confidential - Share Performance and Target Price Review Penumbra Inc (NYSE:PEN)B.O.D.Y ConfidentialDuring the most recent trading session, shares of Penumbra Inc (NYSE:PEN) ended up with a move of +0.20%. Sell-side analysts have given a consensus target price of $58.33 on company shares. Target price projections may differ greatly from one analyst ...and more »
04/29/16 10:38 AMTracking Earnings for Penumbra Inc (NYSE:PEN) - B.O.D.Y Confidential - Tracking Earnings for Penumbra Inc (NYSE:PEN)B.O.D.Y ConfidentialPenumbra Inc (NYSE:PEN) has a current consensus EPS estimate for the quarter of $-0.06 based on Street analyst predictions. The company is scheduled to next report earnings information on or around 2016-05-09 for the period ending 2016-03-31.and more »
04/28/16 10:40 AMPenumbra, Inc. (NYSE:PEN) Updated Broker Price Targets - Share Trading News - Penumbra, Inc. (NYSE:PEN) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Penumbra, Inc. (NYSE:PEN). The latest reports which are currently in issue on Wednesday 27th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/27/16 04:36 PMPenumbra, Inc. to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference - [at noodls] - ALAMEDA, Calif., April 27, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the Bank of America ...
04/27/16 11:29 AMNew Analyst Ratings On Penumbra, Inc. (NYSE:PEN) - Risers & Fallers - New Analyst Ratings On Penumbra, Inc. (NYSE:PEN)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Penumbra, Inc. (NYSE:PEN). The latest broker reports which are currently outstanding on Wednesday 27th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/26/16 11:15 AMPenumbra Inc (NYSE:PEN) Share Rating Recap - The Post - Penumbra Inc (NYSE:PEN) Share Rating RecapThe PostShares of Penumbra Inc (NYSE:PEN) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/26/16 11:15 AMPenumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM ... - PR Newswire (press release) - Penumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM ...PR Newswire (press release)ALAMEDA, Calif., April 25, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter ended March 31, 2016, after market close on Monday, May 9, 2016 at 4:30 PM ...and more »
04/25/16 08:21 PMPenumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM Eastern Time - [at noodls] - ALAMEDA, Calif., April 25, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter ended March 31, 2016, after ...
04/25/16 11:01 AMPenumbra, Inc. (NYSE:PEN) Broker Price Targets For The Coming Week - Share Trading News - Penumbra, Inc. (NYSE:PEN) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Penumbra, Inc. (NYSE:PEN). The latest reports which are currently in issue on Monday 25th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...Brokerages Set $53.00 Price Target for Penumbra Inc (NYSE:PEN)Mas Market Newsall 3 news articles »
About Penumbra

Penumbra logoPenumbra, Inc. (Penumbra) is an interventional therapies company. The Company designs, develops, manufactures and markets medical devices. The Company has a portfolio of products that addresses medical conditions and significant clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. The Company focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Ischemic Stroke, Neurovascular Embolization and Neurosurgical Tools. The Company's peripheral vascular products include Peripheral Embolization and Peripheral Thrombectomy.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PEN
  • CUSIP:
Key Metrics:
  • Previous Close: $58.33
  • 50 Day Moving Average: $55.29
  • 200 Day Moving Average: $50.65
  • P/E Ratio: 940.81
  • P/E Growth: -9.44
  • Market Cap: $1.79B
  • Current Quarter EPS Consensus Estimate: $-0.14 EPS
Additional Links:
Penumbra (NYSE:PEN) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha